Mad Money

Cramer Remix: The market's freak-out creates a fabulous buying opportunity in Funko

Key Points
  • In Funko, "you're literally paying less than nothing for a fabulous beat and raised quarter," CNBC's Jim Cramer says.
  • "I believe at these levels Funko, the stock, is a steal," said the host of the "Mad Money."
  • There are six stocks to keep an eye on that "will give you a sense of when the averages are ready to turn," he says.

CNBC's Jim Cramer is suggesting that investors buy into Funko, the $900 million toymaker that sells pop culture-related collectibles.

In line with a number of stocks that have been sold off even after reporting a strong quarter, Funko shares have lost about $7 since delivering its earnings last week. But Cramer said there was "a lot to love about this quarter," especially because the company gave a full-year forecast that topped Wall Street expectations on sales and earnings guidance.

Closing under $18 on Thursday, Cramer pointed out that the stock is lower than it was in November. It was trading as high as $31 back in September after growing 35 percent in the first half of 2018.

"In other words, you're getting these spectacular results for free," the "Mad Money" host said. "Better than free — you're literally paying less than nothing for a fabulous beat and raised quarter, one of the largest of 2019. So that's why I believe at these levels Funko, the stock, is a steal."

Listen to why Cramer thinks Funko has potential to keep growing here

Stock watch

FedEx Airbus A310-200 freighter taking-off at dusk with a Douglas DC-3, offices and hills behind.
Getty Images

There are a handful of stocks that can give investors early indications about the markets in coming days, Cramer said.

As selling continues and major U.S. indexes take on a "bearish malaise," the host revealed a technique that he developed during his time at Goldman Sachs that helped him forecast which way the wind will blow.

The major indexes continued to slide on Thursday, with the Dow Jones Industrial Average shedding more than 200 points, while the and Nasdaq lost 0.81 percent and 1.13 percent, respectively.

"You need to have the prices and charts of just a half-dozen stocks that ... give you the feel and they tell you the tale of the tape in this market because the action in these names will give you a sense of when the averages are ready to turn," Cramer said. "We had a lot of positive action today, believe it or not, but it may not be there yet."

Click here to find out the stocks Cramer said you need to watch.

Digging for gold

Mark Bristow, chief executive officer Barrick Gold.
Getty Images

Barrick Gold CEO Mark Bristow told CNBC on Thursday that his company and Newmont Mining could more effectively boost gold mining in Nevada as a single operator opposed to a joint venture.

The chief defended the company's competing bid to merge with Newmont, but Newmont CEO Gary Goldberg is interested in merging with Goldcorp for $10 billion. He would rather form a joint venture with Barrick Gold to mine in Nevada.

"There's been debate about the Nevada joint venture. That is a large part of the missing billions," he said in an interview with Cramer.

Learn more about the deal and hear the interview here

Time to log out?

Essdras M Suarez | Boston Globe | Getty Images

LogMeIn, the cloud-based platform for the workplace, is serving one of the hottest spaces of tech and supports about two million daily users.

But after posting strong performances in 2016 and 2017 after an acquisition of GoToMeeting, the stock is down more than 34 percent from this point in 2018. CEO William Wagner is now calling 2019 an investment year to set the company up for another wave of organic growth.

"I've gotta tell you, I'm actually torn on this one," Cramer said. "On the one hand, LogMeIn is the rare value play in the cloud-based software space — the darned thing sells for just 16 times this year's earnings, which is cheaper than a lot of consumer packaged goods companies … let alone software-as-a-service stocks."

Still, LogMeIn recorded more than 20 percent of revenue growth in 2018. Sixteen-times earnings sounds like a "bargain" in a crowded space, the host said.

Get Cramer's verdict here

Curb your cynicism

This photo provided by Janssen Global Services shows Spravato nasal spray.
Janssen Global Services via AP

The U.S. Food and Drug Administration earlier this week approved a drug by Johnson & Johnson that Cramer said was "incredibly positive."

The host is optimistic that Spravato, a treatment for severe depression, could save lives. But the news was met with jokes from cynics comparing it to drugs like ecstasy, he added.

"How many people have to commit suicide in this country before we recognize that it's a good thing when a company like J&J comes up with a new antidepressant? Who cares if it's related to a club drug—the only thing that matters is it works," Cramer said.

While Spravato won't be cheap, Cramer said it could be the biggest breakthrough for depression since Prozac hit the market more than three decades ago.

Hear why Cramer thinks this is good for patients and shareholders here

Cramer's lightning round: A way to cut down on colon cancer

In Cramer's lightning round, he ran through his reactions to callers' stock questions:

EPAM Systems: "I don't know it. I gotta do work. I have not talked about EPAM Systems. We'll do the work."

Exact Sciences Corp.: "It works. It works. Exact Sciences works. It's a way to cut down on colon cancer."

Avalara: "If I'm gonna be in [finance software], I'm gonna be in Intuit. That's the one I like. I-N-T-U."

Philip Morris International: "I don't like to recommend tobacco stocks on this show, I'm sorry. I did have a chartist, he did say that they're good though."

Disclosure: Cramer's charitable trust owns shares of Goldman Sachs.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website?